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Abstract
BACKGROUND—Prodromal syndromes often begin in adolescence – a period of 
neurodevelopmental changes and heightened stress sensitivity. Research has shown elevated stress 
and cortisol in individuals at clinical high risk (CHR) for psychosis. This cross-sectional study 
examined relations of age and pubertal status with cortisol and self-reported stress in healthy 
controls (HCs) and CHR adolescents. It was hypothesized that the relations of age and pubertal 
stage with cortisol and stress would be more pronounced in CHR youth.
METHODS—Participants were 93 HCs and 348 CHR adolescents from the North American 
Prodrome Longitudinal Study (NAPLS). At baseline, measures of stress (Daily Stress Inventory – 
DSI), Tanner stage (TS), and salivary cortisol were obtained.
RESULTS—ANCOVA revealed increased DSI scores with age for both groups, and higher DSI 
scores in CHR adolescents than HCs, with a more pronounced difference for females. Contrary to 
prediction, with age controlled, HCs showed greater TS-related DSI increases. Analysis of cortisol 
showed no significant interactions, but a main effect of age and a trend toward higher cortisol in 
the CHR group. Correlations of cortisol with TS were higher in HC than CHR group.
CONCLUSIONS—Stress measures increased with age in HC and CHR adolescents, and DSI 
scores also increased with TS in HCs. The results do not support a more pronounced age or TS 
increase in stress measures in CHR adolescents, but instead suggest that stress indices tend to be 
elevated earlier in adolescence in the CHR group. Potential determinants of findings and future 
directions are discussed.
Keywords
Schizophrenia; psychosis; puberty; stress; cortisol; Clinical High Risk
1. Introduction
Vulnerability to psychotic disorders is assumed to be congenital (Dempster et al., 2011), but 
its expression appears to be triggered by environmental factors, including stressful events 
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(Dvir et al., 2013). It has been proposed that the adverse effects of stress exposure on 
vulnerable individuals are partially mediated by the consequent increase in activation of the 
hypothalamic pituitary-adrenal (HPA) axis and elevated cortisol secretion (Walker et al., 
2008). In addition, independent of stress, there is evidence that normal neuromaturational 
processes augment stress and cortisol levels during adolescence, and it has been suggested 
that these processes increase risk for onset of the prodrome to serious mental disorders, 
including psychosis (Trotman et al., 2013; Walker et al., 2008). Specifically, the risk for 
psychosis onset rises dramatically following age 13, and increases with each year of age 
through adolescence (de Girolamo et al., 2012; Thorup at al., 2007). In clinical high risk 
(CHR) samples, the prodromal syndrome shows a similar trend, and appears to predate 
psychosis onset by about a year (Chung et al., 2010).
1.1 Adolescent development and stress
Research on normal adolescents has demonstrated that self-reported stress and psychiatric 
symptoms increase with age and pubertal stage (De Vriendt et al., 2011; Lenroot & Giedd, 
2010; Oldehinkel et al., 2011; Rudolph, 2008; Sumter et al., 2010). Similarly, basal cortisol 
increases with both age and pubertal development in healthy adolescents (Sinclair et al., 
2014; Gunnar et al., 2009; Kiess et al., 1995; Matchock et al., 2007; Netherton et al., 2004). 
These findings are consistent with the generalized increase in risk for onset of behavioral 
disorders during adolescence/young adulthood, as well as the notion that the biological 
systems involved in the stress response, including the HPA axis, may play a role in 
triggering the expression of vulnerability (Walker et al., 2008).
While activation of the HPA axis in response to stress is adaptive, prolonged cortisol 
elevations may compromise brain function, which can then contribute to dysregulation of the 
HPA axis and the emergence of psychiatric symptoms (Herbert et al., 2006; Zhu et al., 
2014). Also, independent of stress exposure, the normative rise in cortisol during 
adolescence may increase susceptibility to psychiatric disorders in vulnerable individuals 
(Quevedo et al., 2009; Sontag-Padilla et al., 2012). It has been suggested that increased HPA 
activation following the onset of puberty may increase susceptibility for a range of 
psychiatric syndromes, including psychosis (Trotman et al., 2013).
In recent years, the focus of research on stress and psychotic disorders has shifted towards 
the prodromal phase; individuals who meet standardized criteria for the prodrome are 
designated as CHR, and the estimated rate of conversion to psychosis in this group ranges 
from 20–40% (Larson et al., 2010). Because prodromal syndromes most often arise in 
adolescence/young adulthood, CHR studies focus on this transitional stage (Addington & 
Heinssen, 2012).
To date, findings from CHR research generally parallel those from studies of psychotic 
patients. For example, CHR individuals report more stress than healthy controls (HCs) 
(Cullen et al., 2014; Pruessner et al., 2011). In a report based on the first half of the North 
American Prodrome Study (NAPLS-2) cohort, aged 13 to 30 years, CHR subjects reported 
more daily stress than HCs, and the CHR subjects who subsequently converted to psychosis 
reported greater stress than remitted CHR subjects, with those who remained prodromal 
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falling in between (Trotman et al., 2014). Also, of interest to note, there was a trend for a 
more pronounced relation between stress and age for the CHR group.
With regard to stress biomarkers, there is evidence that CHR subjects manifest heightened 
basal cortisol (Carol & Mittal, 2015; Karanikas & Garyfallos, 2015; Shah & Malla, 2015). 
Another recent report on the first-half cohort from NAPLS-2, again with subjects ranging 
from 13 to 30 years, indicated that both HCs and CHR subjects manifested an age-related 
increase in cortisol through this period (Walker et al., 2013). Further, heightened basal 
cortisol was found in CHR individuals when compared to HCs, and those CHR participants 
who later converted showed higher levels than those who remitted, but not those who 
continued to meet prodromal criteria.
While pubertal development is associated with increased stress and cortisol in healthy 
adolescents, the relation of pubertal stage with these variables in CHR adolescents has not 
yet been examined. Some have proposed that the clinical expression of the prodrome to 
psychosis typically arises in adolescence because it is triggered by abnormalities in the 
timing and/or magnitude of postpubertal neuromaturational processes (Keshavan et al., 
2014; Trotman et al., 2013). It is possible that, when compared to HCs, CHR adolescents 
manifest a more pronounced increase and/or an earlier onset of rising stress indices with the 
progression of puberty, and that this contributes to risk for psychosis. The present study 
addresses this issue by examining the relations of age and pubertal stage with stress and 
cortisol levels in youth from NAPLS-2. The complete sample from this multi-site, 
prospective study now includes over 700 CHR and 200 HC subjects, and a measure of 
Tanner stage (TS) was administered to all of those under 19 years of age. Thus, there are 
now enough subjects in the 13 to 19 year age-range to examine TS. Based on the evidence 
that both stress indices and prodromal/psychotic symptoms increase through the adolescent 
years, and that age-related increases in stress may be greater for CHR subjects (Trotman et 
al., 2014), it is hypothesized that CHR youth will show a more pronounced relation of age 
and Tanner pubertal stage with self-reported daily stress and basal cortisol.
2. Experimental/Materials and methods
2.1 Sample
Participants were drawn from the completed cohort of 764 CHR participants and 280 HCs in 
NAPLS-2 (Addington & Heinssen, 2012). The present subsample includes all participants, 
aged 13 to 18, for whom baseline data on TS, and self-reported stress and/or salivary cortisol 
were obtained; 348 CHR youth and 93 HCs. (Degrees of freedom vary in the analyses, as 
presented below, due to missing data on one of the dependent measures for some subjects.) 
Approximately 50% of these adolescents were included in the previous reports on stress and 
cortisol in the entire first half (13–30 years) of the NAPLS-2 sample. Demographic data on 
the present sample are presented in Table 1.
Exclusion criteria for both groups were substance dependence, neurological disorders, 
serious head trauma, IQ less than 70, and meeting DSM-IV criteria for a psychotic disorder, 
currently or in the past. For the HCs, those with a first-degree relative with psychosis or who 
met prodromal criteria were excluded. Details on sample characteristics and study 
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procedures are presented in previous reports on NAPLS-2 (Addington & Heinssen, 2012; 
Walker et al., 2013).
2.2 Assessment Procedures and Measures
Sites screened participants using the Structured Interview for Prodromal Syndromes (SIPS), 
and diagnosed CHR participants based on the Scale of Prodromal Syndromes (SOPS) at 
baseline (Miller et al., 2003). The Structured Clinical Interview for DSM-IV Disorders was 
used to diagnose Axis I disorders (First et al., 2002).
2.3 Salivary Cortisol
Details about NAPLS-2 saliva collection and cortisol assay procedures are presented in a 
previous report (Walker et al., 2013). In brief, dietary instructions to be observed the evening 
and morning before sampling were provided. Instructions included avoidance of 
nonprescription medications, and foods and beverages known to affect cortisol. At baseline, 
three saliva samples were obtained via passive drool. Multiple samples were obtained in 
order to derive an average and increase the reliability of the cortisol estimate.
Saliva was stored at −20°C. Samples were assayed in duplicate for cortisol (mg/dL) using a 
highly sensitive enzyme immunoassay (Salimetrics, State College, Pennsylvania). The test 
uses about 25 mL of saliva, has a range of sensitivity from 0.007 to 1.8 mg/dL, and average 
intra-assay and inter-assay coefficients of variation of less than 10% and 15%.
2.4 Pubertal Stage
A self-report measure of pubertal status, the Tanner Scale (Petersen et al., 1988), was 
administered to NAPLS-2 subjects who were between the ages of 13 and 18. The Tanner 
scale is a gender-specific, one-page self-assessment that uses drawings of standard 
photographs illustrating breast and genital development. Tanner stages range from 1–5, with 
1 indicating the beginning of puberty to 5, the most mature stage. The scale was selected 
because it is less invasive than examination and has good reliability and validity (Forbes et 
al., 2010). The scale yields two scores for males (pubic score and penis score) and for 
females (pubic score and breast score). The TS was designated based on the average total 
score on the two dimensions within gender. Because only a small number of subjects (n = 2) 
self-rated in TS 1 on the scale, stages 1 and 2 were combined.
2.5 Daily Stress
The Daily Stress Inventory (DSI) is a 58-item measure of stressors over the past 24 hours 
(Brantley et al., 1987). Items include “misplaced something”, “encountered bad weather”, 
“was interrupted during task/activity”, and “had sleep disturbed.” The DSI has been utilized 
with healthy and clinical adolescent samples, and the results support its validity and 
reliability with this age range (Gallaty & Zimmer-Gembeck, 2008; Tessner, Mittal, & 
Walker, 2011; White & Shih, 2012). Participants indicated whether the event occurred and 
rated each on a 7-point scale, ranging from “occurred, but was not very stressful” to “caused 
me to panic.” Ratings of stressfulness were summed to derive a total score, and the 
distribution normalized with logarithmic transformation.
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2.6 Data Analyses
Using the Statistical Package for the Social Sciences (SPSS), Pearson correlations were 
computed, followed by analyses of covariance (ANCOVAS-GLM), with age as the 
covariate, sex, TS, and diagnostic group (CHR versus HC) as the independent variables, and 
cortisol and DSI as dependent variables. Age was included as a covariate to determine the 
independent effects of TS. For ANCOVA of cortisol, saliva sampling time was also 
controlled, due to the diurnal fluctuations in secretion.
3. Results
There were no significant differences between the CHR and HC groups in age, sex ratio, or 
TS (See Table 1). Bivariate correlations, by group and sex, are presented in Table 2. (It is 
important to note that the sex groups differed in size, and consequentially in power for 
detecting significant relations.) For the HC group, all coefficients were positive and most 
statistically significant. Although all coefficients were positive for the CHR group, the 
magnitudes were smaller and more did not reach significance. Using r-to-Z transformation 
for comparing the group differences, there were three differences at p<.05, with higher 
correlations for the HC group (See underlined values in Table 2). The relation of TS with 
cortisol was higher for HCs of both sexes than for CHR subjects. Also, the relation of male 
TS with age was higher for HCs. As expected, for both groups, age was correlated with male 
and female TS, DSI scores, and cortisol. The nonsignificant correlations of DSI scores and 
cortisol in both groups suggest that the two are primarily indexing independent constructs.
The above correlational analyses did not test the effects of TS independent of age. The 
ANCOVAS of DSI scores, with age as a covariate, yielded significant main effects of age 
[F(1, 392) =13.010, p<.001, eta2=.03] and diagnostic group [F(1, 392) =39.02, p<.001, 
eta2=.09], and a trend toward a main effect of TS [F(3, 392) =2.52, p=.06, eta2=.19]. As 
reported previously for the 13 to 30 year-old NAPLS-2 sample (Trotman et al., 2014), the 
CHR adolescents in this subsample had higher DSI scores than the HC group and, as age 
increased from 13 to 18, scores increased for both groups. However, these main effects were 
qualified by significant two-way interactions: TS X Diagnostic Group, [F(3, 392) =2.73, p<.
05, eta2=.021], and Sex × Diagnostic Group, [F(3, 392) =9.42, p<.05, eta2=.023].
As illustrated in Figure 1, when controlling for age, the DSI scores for CHR subjects were 
elevated relative to HCs across all TSs. To further explore the significant TS × Diagnostic 
Group interaction, post hoc tests were conducted. In all TSs, the CHR showed significantly 
higher DSI scores than the HC group (TS 2, t(1, 16) = 3.30, p=.005; TS 3, t(1, 76) = 2.75, 
p=.00; TS 4, t(1, 153) = 2.24, p=.03, TS 5, t(1, 159) = 6.01, p=.000). Comparing TSs within 
group, the HC group showed a rise in DSI scores when comparing TS 2 to subsequent 
stages; TS 3 (t(1, 15) = 2.06, p<.05), TS 4 (t(1,28) = 3.75, p=.001) and TS 5, t(1,45) = 2.91, 
p=0.01, but no significant increase between stages 3, 4 and 5. In contrast, there was little 
change in DSI scores with TS in the CHR group; specifically, there was no significant rise 
beyond TS 2, although those in TS 5 reported significantly higher stress compared to those 
in TS 4, (t(1, 247)= 2.60, p=.01).
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The significant Sex × Diagnostic Group interaction is illustrated in Figure 2, and is due to a 
significant difference in self-reported stress between female and males subjects in the CHR 
group, t(1,347)= 4.14, p<.001, but not in the HC group, t(1,92)= .464, p=.64.
ANCOVA of cortisol levels yielded a significant main effect of the covariate age, [F(1, 295) 
=7.12, p<.01, eta2=0.024], consistent with the positive correlations between age and cortisol 
reported above, and a trend for Diagnostic Group [F(1, 295) =3.73, p=0.05, eta2=0.012], 
with higher cortisol levels in the CHR than HC group. There were, however, no main effects 
for TS or sex, and no significant interactions.
4. Discussion
The present results indicate that stress and cortisol secretion increase with age in HC and 
CHR adolescents, and that the latter group is characterized by greater stress. But, contrary to 
prediction, when controlling for age, the changes in stress as a function of TS were more 
pronounced in HCs than in the CHR group. Further, the correlations of age and TS with 
stress did not differ in magnitude for the two groups. In the following, we discuss the 
findings separately by measure.
As mentioned, a study of the entire age-range in the first half of the NAPLS-2 cohort 
revealed an increase in DSI scores with age for both diagnostic groups, as well as higher 
DSI scores for the CHR group relative to controls (Trotman et al., 2014). These findings 
hold for the present subsample of adolescents. In addition, when controlling for age, TS 
interacted with group to account for a significant proportion of the variance in self-reported 
stress. This interaction reflected a rise in mean DSI scores as a function of TS in the HC 
group, particularly when comparing TS 2 to subsequent stages. But for the CHR group there 
was relatively less change across TSs. Thus, it possible that CHR participants experienced a 
rise in subjective stress that occured prior to, or earlier, in the course of pubertal 
development than is normally the case, and that this elevation is sustained through 
subsequent stages. Of course, this study is cross-sectional, so we do not know what the 
stress/cortisol levels of the older CHR subjects were in earlier stages.
Diagnostic group also moderated the relation of sex with stress. While both male and female 
CHR subjects reported greater stress than same-sex HC subjects, the group difference was 
more pronounced for females. It is well established that females report higher stress than 
males, apparently beginning in adolescence (Hastings et al., 1996; Hyde et al., 2008; 
Leadbeater et al., 1995; Matud, 2004), and there is evidence that the magnitude of the 
difference is greater in clinical populations (Hastings et al., 1996; Matud, 2004). It has been 
suggested that this is due to biological and psychological differences that increase 
postpubertally and heighten the tendency for females to experience and describe events as 
stressful. Similarly, the amplification of the sex difference in CHR adolescents in the present 
study may indicate that CHR females experience symptoms as more distressing than CHR 
males. Further research is needed to elucidate this difference.
There was no relation of cortisol with TS, independent of age, but there was an age-related 
increase and a trend toward a diagnostic group difference in this adolescent sample. Again, 
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there was no evidence of a greater relation between TS and cortisol in the CHR group; in 
fact, the opposite was the case when age was not controlled. Differences between age and 
TS in their pattern of relations with biological and psychological variables have been 
documented in previous studies of adolescents (Blum et al., 1997; Goddings et al., 2014), 
and this has been attributed to differences between the processes indexed by measures of 
physical changes (ie., TS indicators), versus those captured by chronological age, which 
more broadly indexes cumulative exposures and maturational processes that extend into 
early adulthood. Also, differences in measurement reliability should be considered; it is 
reasonable to assume that there is minimal error in the measurement of age, whereas TS 
reliability is influenced by multiple factors. The physical manifestations on which TS is 
based are “proxy” measures of underlying hormonal changes. Further, self-report is another 
potential source of error, and this may be greater in CHR than control youth.
Measurement error and confounds are also an issue to consider with the DSI. As with all 
self-report measures of stress, responses to some of the items, or their occurrence of some of 
the stressors, may be attributable to psychopathology. Disentangling the direction of causal 
effects would be facilitated by repeated-measures designs, such as the experience sampling 
method (ESM) used by Collip and colleagues (Collip et al., 2011), which does suggest that 
increases in stress precipitate increases in psychiatric symptom severity. Further, for this 
adolescent subsample from NAPLS-2, the cross-sectional relationship between DSI scores 
and cortisol did not reach significance. The ESM study, cited above, did reveal a moderate 
but significant positive relation between daily stress and cortisol in genetic high-risk subjects 
(Collip et al., 2011), and a longitudinal study using the DSI with healthy subjects revealed a 
positive relation with cortisol (Brantley et al., 1988). Similary, a cross-sectional study of 
healthy subjects found a positive relation of daily stress with cortisol, but it varied in 
magnitude as a function of family environment (Hanson & Chen, 2010). Yet, in contrast, one 
report on first episode psychosis patients indicated an inverse relation between recent stress 
and cortisol (Mondelli et al., 2010), although most of the patients were on antipsychotics 
which is associated with cortisol suppression. Another study of CHR subjects found an 
inverse relation of cortisol with stress in the past year (Pruessner et al., 2013). Both of the 
latter two studies were cross-sectional, so it is possible that cross-sectional designs do not 
afford the level of statistical power for detecting relations between stress and cortisol that 
would be obtained with repeated-measures designs such as ESM. It is clear that further 
research is needed to identify the determinants of differences among studies in their 
findings; investigations that examine both cross-sectional and longitudinal relations in the 
same sample may be especially informative.
Another limitation of this study is that inclusion in a CHR group requires the presence of a 
prodromal syndrome which has a low incidence in pre- and early-puberty; The present 
sample contained only two individuals in TS 1. Obtaining more CHR subjects in TS 1 would 
require a larger sample than NAPLS-2, or targeted recruitment of these individuals.
4.1 Conclusions
Our findings reveal a relation between TS and stress that differs for CHR and HC subjects. 
HCs showed a greater rise in DSI with TS, whereas CHR youth manifest elevated DSI 
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scores throughout the TSs measured here, with the most pronounced elevation relative to 
controls in the earliest TS. This may indicate that, for CHR youth, the normative changes 
associated with puberty onset are more stressful, that antecedent influences (e.g., childhood 
stress/trauma) have amplified self-reported stress, and/or that there is an abnormality in 
pubertal neuromaturational processes. As noted, some previous research shows that life 
event stress exposure is higher in CHR subjects, and this may set the stage for a more 
pronounced increase in subjective stress in early adolescence. With respect to 
neuromaturation, research has shown brain abnormalities in CHR subjects, including reports 
of a reduction in hippocampal volume (Nenadic et al., 2015). The hippocampus is involved 
in negative feedback to the HPA axis, so this abnormality may contribute to elevated stress 
in CHR youth. Finally, CHR subjects may experience abnormalities in gonadal hormones 
that amplify stress-sensitivity through pubertal development. We hope to address these 
alternative possibilities in future studies.
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Figure 1. 
Mean Daily Stress Inventory (DSI) Scores by Tanner stage in the CHR and HC Groups.
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Figure 2. 
Mean DSI Scores by Sex and Diagnostic Group.
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Table 1
Demographic and Clinical Characteristics
Healthy Controls
N=348
CHR
N=93
Baseline Age
M (SD), n
Males 14.93 (1.83), 60 15.78 (1.72), 196
Females 15.63 (1.81), 33 15.36 (1.61), 152
Tanner Total Male Score
M (SD) 8.18 (1.95) 8.26 (1.64)
Tanner Total Female Score
M (SD) 7.67 (1.88) 7.25 (1.65)
Schizophr Res. Author manuscript; available in PMC 2017 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Moskow et al. Page 16
Ta
bl
e 
2
Co
rre
la
tio
ns
 a
m
on
g 
M
ea
su
re
s f
or
 C
H
R 
an
d 
H
C 
Sa
m
pl
es
.
Pe
a
rs
o
n
 C
or
re
la
tio
ns
BC
D
SI
A
ge
TM
TF
B
C
1
0.
08
0.
13
*
0.
07
0.
01
D
SI
0.
14
1
0.
19
*
0.
25
*
0.
09
A
ge
0.
34
*
0.
29
*
1
0.
46
*
0.
27
*
TM
0.
31
*
0.
24
*
0.
66
*
1
TF
0.
35
*
0.
27
0.
40
*
1
U
pp
er
 ri
gh
th
an
d 
pa
rt
 
o
f t
he
 ta
bl
e 
de
no
te
s c
or
re
la
tio
ns
 fo
r C
H
R 
su
bje
cts
; b
ott
om
 lo
w
er
 le
ft 
of
 th
e 
ta
bl
e 
de
no
te
s c
or
re
la
tio
ns
 fo
r h
ea
lth
y 
co
nt
ro
ls.
N
ot
e. 
B
C 
= 
Ba
se
lin
e 
Co
rti
so
l; 
D
SI
 =
 D
ai
ly
 S
tre
ss
 In
v
en
to
ry
 sc
or
e;
 T
M
 =
 T
an
n
er
 to
ta
l M
al
e 
sc
or
e;
 T
F 
= 
Ta
n
n
er
 to
ta
l F
em
al
e 
sc
or
e.
*
In
di
ca
te
s c
or
re
la
tio
n 
sig
ni
fic
an
t a
t 0
.0
5.
U
nd
er
lin
ed
 v
al
ue
s i
nd
ic
at
e 
sig
ni
fic
an
t d
ia
gn
os
tic
 g
ro
up
 d
iff
er
en
ce
s i
n 
co
rre
la
tio
n 
co
ef
fic
ie
nt
 m
ag
ni
tu
de
, u
sin
g 
r-t
o-
Z 
tra
ns
fo
rm
at
io
n 
at
 p
< 
.0
5.
Schizophr Res. Author manuscript; available in PMC 2017 April 01.
